A Retrospective Study for Nimotuzumab Plus Postoperative Adjuvant Chemotherapy for Resectable Pancreatic Cancer

Clinical trial NCT06363084 · COMPLETED

Trial details

NCT number: NCT06363084
Sponsor: Ruijin Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Resectable Pancreatic Cancer

Start date: 2016-05-01
Primary completion: 2022-07-31
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.